Type I Gaucher disease in children with and without enzyme therapy

Pediatric Hematology and Oncology

Volumn 19, Issue 6, 2002, Pages 389-397

  Dweck, Altoon ^a   Abrahamov, Ayala ^a   Hadas Halpern, Irith ^a   Bdolach Avram, Tali ^a   Zimran, Ari ^a   Elstein, Deborah ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Children; Enzyme replacement therapy; Gaucher disease; Growth retardation; Splenomegaly

Indexed keywords

ALGLUCERASE; IMIGLUCERASE; GLUCOSYLCERAMIDASE; HEMOGLOBIN;

ADULT; ARTICLE; CATHETER INFECTION; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME REPLACEMENT; ENZYME THERAPY; FEMALE; FOLLOW UP; GAUCHER DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT; BLOOD; BODY HEIGHT; BODY WEIGHT; CHILD; INFANT; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEMOGLOBINS; HUMAN; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; SPLENECTOMY; HUMANS;

EID: 0036707987     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010290097143     Document Type: Article

References (12)

1. The clinical course of treated and untreated Gaucher disease: A study of 45 patients
2. Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatment
3. Enzyme therapy in Gaucher disease type I: Dosage, efficacy and adverse effects in 33 patients treated for 6 to 24 months
4. Low-close high-frequency enzyme replacement therapy for very young children with severe Gaucher disease
5. Physical growth and development
6. Prediction of severity of Gaucher's disease by identification of mutations at DNA level
7. Phenotype/genotype correlations in Gaucher disease type I: Clinical and therapeutic implications
8. Eponym series: Gaucher's disease
9. Outcome of partial splenectomy for type I Gaucher disease
10. Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy
11. Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase
12. Successful enzyme replacement therapy (ERT) in children using high starting and reducing maintenance dosage